The inhibition of GLI1 following chemotherapy may serve as a novel strategy to ensure the crucial killing effect of chemotherapy on tumour cells and inhibit the chemotherapy-exacerbated metastasis in ovarian cancer treatment. The gene discussed is GLI1; the disease is ovarian carcinoma.